COEPTIS THERAPEUTICS HLDGS I

Historical 13F Holders

Symbol
COEP
CUSIP
19207A207
All holders as of
Q1 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 19207A207 since 12/18/2024, newest first.

Filer % of Class Filed
BSG Series CM, LLC 13D/A Amendment 1 0% 5/15/2026
Event 4/30/2026
Vanguard Capital Management LLC 13G
5.6% 5/4/2026
Event 3/31/2026
BSG Series CM, LLC 13D 80.7% 5/4/2026
Event 4/24/2026
Vanguard Capital Management LLC 13G 5.6% 4/28/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 1 0% 3/26/2026
Event 3/13/2026
Vanguard Group Inc 13G
6.4% 1/30/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 12 478 k $5.36 M
2025 Q4 14 458 k $6.53 M
2025 Q3 10 138 k $2.40 M
2025 Q2 10 102 k $795 k
2025 Q1 10 55.2 k $518 k
2024 Q4 6 8.50 k $44.4 k